Moderna (MRNA)
(Delayed Data from NSDQ)
$65.69 USD
-2.33 (-3.43%)
Updated Sep 20, 2024 04:00 PM ET
After-Market: $65.65 -0.04 (-0.06%) 7:58 PM ET
4-Sell of 5 4
F Value C Growth F Momentum F VGM
Moderna (MRNA) Price Targets
Average Price Target | Highest Price Target | Lowest Price Target | Upside to Average Price Target |
---|---|---|---|
$108.84 | $238.00 | $48.00 | 60.01% |
Price Target
Based on short-term price targets offered by 19 analysts, the average price target for Moderna comes to $108.84. The forecasts range from a low of $48.00 to a high of $238.00. The average price target represents an increase of 60.01% from the last closing price of $68.02.
Analyst Price Targets (19)
Broker Rating
Moderna currently has an average brokerage recommendation (ABR) of 2.65 on a scale of 1 to 5 (Strong Buy to Strong Sell), calculated based on the actual recommendations (Buy, Hold, Sell etc.) made by 23 brokerage firms. The current ABR compares to an ABR of 2.43 a month ago based on 23 recommendations.
Of the 23 recommendations deriving the current ABR, six are Strong Buy, representing 26.09% of all recommendations. A month ago, Strong Buy represented 34.78%.
Broker Rating Breakdown
Brokerage Recommendations
Today | 1 Week Ago | 1 Month Ago | 2 Months Ago | 3 Months Ago | |
---|---|---|---|---|---|
Strong Buy | 6 | 6 | 8 | 8 | 8 |
Buy | 0 | 0 | 0 | 1 | 1 |
Hold | 15 | 15 | 13 | 11 | 10 |
Sell | 0 | 0 | 1 | 1 | 1 |
Strong Sell | 2 | 2 | 1 | 2 | 2 |
ABR | 2.65 | 2.65 | 2.43 | 2.48 | 2.45 |
1. Not Ident. Many of the brokerage firms who provide Zacks data ask that we keep their identity confidential.
2. In most cases the # of brokers listed above is less than the # of brokerage firms that have a recommendation on the stock. That is because some firms prohibit Zacks from displaying detailed information on their recommendations such as in the upgrade/downgrade table.
Analyst Upgrades/Downgrades
Date | Brokerage Firm | Analyst | Previous | Current |
---|---|---|---|---|
9/17/2024 | SVB Securities | Mani Foroohar | Strong Sell | Strong Sell |
9/16/2024 | Evercore Partners | Cory Kasimov | Hold | Hold |
9/13/2024 | Cowen & Co. | Tyler Van Buren | Hold | Hold |
9/13/2024 | Piper Sandler | Edward A Tenthoff | Strong Buy | Strong Buy |
9/13/2024 | Not Identified | Not Identified | Strong Buy | Hold |
9/13/2024 | Not Identified | Not Identified | Hold | Hold |
9/12/2024 | Chardan Capital Markets | Yevgeniya Livshits | Hold | Hold |
9/12/2024 | Brookline Capital Markets | Leah R Cann | Strong Buy | Strong Buy |
8/28/2024 | Not Identified | Not Identified | Moderate Sell | Hold |
8/21/2024 | Argus Research Corp. | Jasper Hellweg | Strong Buy | Strong Buy |
8/16/2024 | William Blair | Myles R Minter | Hold | Hold |
8/5/2024 | Not Identified | Not Identified | Moderate Buy | Hold |
8/2/2024 | Not Identified | Not Identified | Strong Buy | Strong Buy |
8/2/2024 | UBS | Eliana Merle | Strong Buy | Strong Buy |
8/2/2024 | Goldman Sachs | Salveen Richter | Strong Buy | Strong Buy |
7/10/2024 | Atlantic Equities | Simon Baker | Not Available | Hold |
6/28/2024 | Needham & Company | Joseph R Stringer | Hold | Hold |
5/3/2024 | Canaccord Genuity | William Maughan | Hold | Hold |
3/28/2024 | Guggenheim Securities | Evan Wang | Hold | Hold |
1. Not Ident. Many of the brokerage firms who provide Zacks data ask that we keep their identity confidential.
2. In most cases the # of brokers listed above is less than the # of brokerage firms that have a recommendation on the stock. That is because some firms prohibit Zacks from displaying detailed information on their recommendations such as in the upgrade/downgrade table.
Average Brokerage Rating
Current ABR | 2.65 |
ABR (Last week) | 2.65 |
# of Recs in ABR | 23 |
Average Target Price | $108.74 |
LT Growth Rate | 16.60% |
Industry | Medical - Biomedical and Genetics |
Industry Rank by ABR | 79 of 253 |
Current Quarter EPS Est: | -1.84 |
MRNA FAQs
Moderna, Inc. (MRNA) currently has an average brokerage recommendation (ABR) of 2.65 on a scale of 1 to 5 (Strong Buy to Strong Sell), calculated based on the actual recommendations (Buy, Hold, Sell etc.) made by 23 brokerage firms.
The average price target for Moderna, Inc. (MRNA) is $108.74. The current on short-term price targets is based on 12 reports.
The forecasts for Moderna, Inc. (MRNA) range from a low of $46 to a high of $238. The average price target represents a increase of $65.54 from the last closing price of $65.69.
The current UPSIDE for Moderna, Inc. (MRNA) is 65.54%
Based on short-term price targets offered by 19 analysts, the average price target for Moderna comes to $108.84. The forecasts range from a low of $48.00 to a high of $238.00. The average price target represents an increase of 60.01% from the last closing price of $68.02.